Skip to main content
Log in

Diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus: a meta-analysis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To systematically evaluate the diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus (SLE). Studies were searched in PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), and China Biology Medicine (CBM) disc database, and languages were limited in English and Chinese. QUADAS-2 tool was applied to assess the quality of eligible studies. Random-effect model was applied to calculate pooled effects of miRNAs on diagnosing SLE. Subgroup analysis was used to explore the sources of heterogeneity. All data were calculated and analyzed by Meta-Disc 1.4 and RevMan 5.3 software. Six eligible studies were included in this meta-analysis. The pooled sensitivity, specificity, and diagnostic odds ratio of miRNAs were 0.75(95% CI 0.71–0.79), 0.72(95% CI 0.66–0.78), and 8.79(95% CI 4.91–15.73), respectively. The pooled positive likelihood ratio was 2.71(95% CI 2.20–3.33) and negative likelihood ratio was 0.34(95% CI 0.24–0.48). The area under the curve was 0.787. The subgroup analysis showed that the number of healthy controls might be the sources of heterogeneity. MiRNAs in blood have moderate accuracy and influence on diagnosing SLE, and the exact diagnostic value should be confirmed by further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Diniz-da-Costa T, Centeno M, Pinto L, Marques A, Mendes-Graca L (2012) Systemic lupus erythematosus and pregnancy. Acta medica portuguesa 25(6):448–453

    PubMed  Google Scholar 

  2. Ahmadpoor P, Dalili N, Rostami M (2014) An update on pathogenesis of systemic lupus erythematosus. Iranian journal of kidney diseases 8(3):171–184

    PubMed  Google Scholar 

  3. Pradhan V, Patwardhan M, Rajadhyaksha A, Ghosh K (2013) Clinical and immunological profile of systemic lupus erythematosus. Indian Pediatr 50(4):405–407

    Article  CAS  PubMed  Google Scholar 

  4. Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M (2015) The diagnosis and treatment of systemic lupus erythematosus. Deutsches Arzteblatt international 112(25):423–432. https://doi.org/10.3238/arztebl.2015.0423

    Article  PubMed  PubMed Central  Google Scholar 

  5. Adinolfi A, Valentini E, Calabresi E, Tesei G, Signorini V, Barsotti S, Tani C (2016) One year in review 2016: systemic lupus erythematosus. Clin Exp Rheumatol 34(4):569–574

    PubMed  Google Scholar 

  6. Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 48-49:10–13. https://doi.org/10.1016/j.jaut.2014.01.004

    Article  CAS  PubMed  Google Scholar 

  7. Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Asanuma YF, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mimori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T (2017) Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC). Mod Rheumatol:1–7. https://doi.org/10.1080/14397595.2017.1385154

    Article  PubMed  Google Scholar 

  8. Wichainun R, Kasitanon N, Wangkaew S, Hongsongkiat S, Sukitawut W, Louthrenoo W (2013) Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems. Asian Pac J Allergy Immunol 31(4):292–298. https://doi.org/10.12932/ap0272.31.4.2013

    Article  CAS  PubMed  Google Scholar 

  9. Flechsig A, Rose T, Barkhudarova B, Strauss R, Klotsche J, Dähnrich C, Schlumberger W, Enghard P, Burmester GR, Hiepe F, Biesen R (2017) What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3. Clin Exp Rheumatol 35:598–606

    PubMed  Google Scholar 

  10. Parkpian V, Verasertniyom O, Vanichapuntu M, Totemchokchyakarn K, Nantiruj K, Pisitkul P, Angchaisuksiri P, Archararit N, Rachakom B, Ayurachai K, Janwityanujit S (2007) Specificity and sensitivity of anti-β2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome. Clin Rheumatol 26:1663–1670. https://doi.org/10.1007/s10067-007-0566-5

    Article  PubMed  Google Scholar 

  11. Hausser J, Syed AP, Selevsek N, van Nimwegen E, Jaskiewicz L, Aebersold R, Zavolan M (2013) Timescales and bottlenecks in miRNA-dependent gene regulation. Mol Syst Biol 9:711. https://doi.org/10.1038/msb.2013.68

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lenkala D, Gamazon ER, LaCroix B, Im HK, Huang RS (2015) MicroRNA biogenesis and cellular proliferation. Translational research : the journal of laboratory and clinical medicine 166(2):145–151. https://doi.org/10.1016/j.trsl.2015.01.012

    Article  CAS  Google Scholar 

  13. Georgi N, Taipaleenmaki H, Raiss CC, Groen N, Portalska KJ, van Blitterswijk C, de Boer J, Post JN, van Wijnen AJ, Karperien M (2015) MicroRNA levels as prognostic markers for the differentiation potential of human mesenchymal stromal cell donors. Stem Cells Dev 24(16):1946–1955. https://doi.org/10.1089/scd.2014.0534

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, Mansuria S, Elishaev E, Budiu R, Edwards RP, Huang X (2013) Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 19(5):1213–1224. https://doi.org/10.1158/1078-0432.ccr-12-2726

    Article  CAS  Google Scholar 

  15. Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, Rosenwaks Z, Tuschl T (2013) Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A 110(11):4255–4260. https://doi.org/10.1073/pnas.1214046110

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ono S, Oyama T, Lam S, Chong K, Foshag LJ, Hoon DS (2015) A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients. Oncotarget 6(9):7053–7064. https://doi.org/10.18632/oncotarget.3142

    Article  PubMed  PubMed Central  Google Scholar 

  17. Filkova M, Aradi B, Senolt L, Ospelt C, Vettori S, Mann H, Filer A, Raza K, Buckley CD, Snow M, Vencovsky J, Pavelka K, Michel BA, Gay RE, Gay S, Jungel A (2014) Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis 73(10):1898–1904. https://doi.org/10.1136/annrheumdis-2012-202815

    Article  CAS  PubMed  Google Scholar 

  18. Li M, Zhang J (2015) Circulating MicroRNAs: potential and emerging biomarkers for diagnosis of cardiovascular and cerebrovascular diseases. Biomed Res Int 2015:730535. https://doi.org/10.1155/2015/730535

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Thirion M, Ochiya T (2013) Roles of microRNAs in the hepatitis B virus infection and related diseases. Viruses 5(11):2690–2703. https://doi.org/10.3390/v5112690

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Peng Y, Li C, Luo DC, Ding JW, Zhang W, Pan G (2014) Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma. Molecules (Basel, Switzerland) 19(8):11586–11599. https://doi.org/10.3390/molecules190811586

    Article  CAS  Google Scholar 

  21. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536. https://doi.org/10.7326/0003-4819-155-8-201110180-00009

    Article  PubMed  Google Scholar 

  22. Dinnes J, Deeks J, Kirby J, Roderick P (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health technology assessment (Winchester, England) 9(12):1–113 iii

    CAS  Google Scholar 

  23. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM (2008) Systematic reviews of diagnostic test accuracy. Ann Intern Med 149(12):889–897

    Article  PubMed  PubMed Central  Google Scholar 

  24. Navarro-Quiroz E, Pacheco-Lugo L, Lorenzi H, Diaz-Olmos Y, Almendrales L, Rico E, Navarro R, Espana-Puccini P, Iglesias A, Egea E, Aroca G (2016) High-throughput sequencing reveals circulating miRNAs as potential biomarkers of kidney damage in patients with systemic lupus erythematosus. PLoS One 11(11):e0166202. https://doi.org/10.1371/journal.pone.0166202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Motawi TK, Mohsen DA, El-Maraghy SA, Kortam MA (2016) MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus. Chem Biol Interact 260:110–116. https://doi.org/10.1016/j.cbi.2016.11.001

    Article  CAS  PubMed  Google Scholar 

  26. Tang ZM, Fang M, Wang JP, Cai PC, Wang P, Hu LH (2014) Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients. J Clin Lab Anal 28(6):446–451. https://doi.org/10.1002/jcla.21708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lu YL, FAN CF, Xi HX, Qiang GG, Di ZH, Fang ZL, Ai LQ, Yang XX (2016) Detection of the plasma miR-23a expression in systemic lupus erythematosus and its clinical significance. Journal of Wenzhou Medical University 46(3):168–173. https://doi.org/10.3969/j.issn.2095-9400.2016.03.003

    Article  Google Scholar 

  28. Yang H, Song GX, Ping W (2016) Changes in levels of serum miR-155 in patients with systemic lupus erythematosus. Shandong Medical Journal 56(45):27–30. https://doi.org/10.3969/j.issn.1002-266X.2016.45.008

    Article  Google Scholar 

  29. Juan XL, Lu YL, Qiong CA, Xi HX, Di ZH, Sheng CC, Yang XX (2015) Expression of miR-29a in plasma of patients with systemic lupus erythematosus and its clinical significance. Zhejiang Medical Journal 37(19):1565–1569

    Google Scholar 

  30. Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148(6):1172–1187. https://doi.org/10.1016/j.cell.2012.02.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Noonan EJ, Place RF, Basak S, Pookot D, Li LC (2010) miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1(5):349–358. https://doi.org/10.18632/oncotarget.167

    Article  PubMed  PubMed Central  Google Scholar 

  32. Dumortier O, Hinault C, Van Obberghen E (2013) MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 18(3):312–324. https://doi.org/10.1016/j.cmet.2013.06.004

    Article  CAS  PubMed  Google Scholar 

  33. Tunnicliffe DJ, Singh-Grewal D, Kim S, Craig JC, Tong A (2015) Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines. Arthritis care & research 67(10):1440–1452. https://doi.org/10.1002/acr.22591

    Article  Google Scholar 

  34. Choi J, Kim ST, Craft J (2012) The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol 24(6):651–657. https://doi.org/10.1016/j.coi.2012.10.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kamen DL (2014) Environmental influences on systemic lupus erythematosus expression. Rheum Dis Clin N Am 40(3):401–412, vii. https://doi.org/10.1016/j.rdc.2014.05.003

    Article  Google Scholar 

  36. Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC (2013) Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol 173(1):47–57. https://doi.org/10.1111/cei.12089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Maurer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O (2010) MicroRNA-29: a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62(6):1733–1743. https://doi.org/10.1002/art.27443

    Article  CAS  PubMed  Google Scholar 

  38. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10(4):R101. https://doi.org/10.1186/ar2493

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Pauley KM, Cha S, Chan EK (2009) MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32(3–4):189–194. https://doi.org/10.1016/j.jaut.2009.02.012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lech M, Anders HJ (2013) The pathogenesis of lupus nephritis. J Am Soc Nephrol: JASN 24(9):1357–1366. https://doi.org/10.1681/asn.2013010026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating MicroRNA: preanalytical and analytical challenges. Clin Chem 57(6):833–840. https://doi.org/10.1373/clinchem.2010.157198

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by Grants National Natural Science Foundation of China (No. 81573217, 81172764), and Scientific Research of BSKY from Anhui Medical University (No. XJ201301).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Bin Wang or Dong-Qing Ye.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dai, ZW., Wang, H., Xu, WJ. et al. Diagnostic accuracy of miRNAs as potential biomarkers for systemic lupus erythematosus: a meta-analysis. Clin Rheumatol 37, 2999–3007 (2018). https://doi.org/10.1007/s10067-018-4189-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4189-9

Keywords

Navigation